Daré Bioscience (DARE) Institutional Ownership $4.23 0.00 (0.00%) (As of 10/31/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Daré Bioscience (NASDAQ:DARE)CurrentInstitutional OwnershipPercentage6.70%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$35.92MNumber ofInstitutional Sellers(last 12 months)0 Get DARE Insider Trade Alerts Want to know when executives and insiders are buying or selling Daré Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DARE Institutional Buying and Selling by Quarter Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Daré Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/9/2024Renaissance Technologies LLC778,700$262K0.0%+2.1%9.247% 11/15/2023Armistice Capital LLC6,470,000$2.99M0.0%N/A7.370% 5/1/2023Virtu Financial LLC32,481$34K0.0%-58.1%0.038% 2/8/2023Founders Financial Securities LLC114,000$95K0.0%-67.2%0.134% 11/7/2022Virtu Financial LLC68,242$68K0.0%+29.2%0.080% 10/27/2022Founders Financial Securities LLC347,824$5.27M0.9%+236.1%0.410% Get the Latest News and Ratings for DARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter. 7/27/2022Founders Financial Securities LLC103,500$127K0.0%N/A0.122% 7/19/2022Commonwealth Equity Services LLC43,579$53K0.0%+57.8%0.051% 5/11/2022GSA Capital Partners LLP125,954$188K0.0%-11.2%0.150% 5/10/2022Buckingham Strategic Partners30,000$45K0.0%+200.0%0.036% 2/14/2022GSA Capital Partners LLP141,843$284K0.0%+1,077.5%0.185% 2/8/2022Raymond James Financial Services Advisors Inc.30,000$60K0.0%N/A0.039% 11/15/2021HighTower Advisors LLC22,035$36K0.0%-26.6%0.031% 11/12/2021Renaissance Technologies LLC324,030$541K0.0%+346.4%0.459% 11/10/2021Goldman Sachs Group Inc.255,282$426K0.0%+1,349.9%0.362% 11/9/2021BlackRock Inc.122,725$205K0.0%-9.0%0.174% 10/19/2021Interwest Venture Management Co.62,065$104K0.0%+23.2%0.088% 10/15/2021 Paradigm Strategies in Wealth Management LLC23,105$39K0.0%+131.1%0.033% 8/16/2021State Street Corp62,630$118K0.0%N/A0.127% 8/13/2021Renaissance Technologies LLC72,590$137K0.0%-91.7%0.147% 8/13/2021Geode Capital Management LLC310,318$586K0.0%+19.7%0.629% 8/13/2021Vanguard Group Inc.1,941,258$3.67M0.0%+37.2%3.934% 8/12/2021XTX Topco Ltd14,101$27K0.0%N/A0.029% 8/11/2021Commonwealth Equity Services LLC25,875$48K0.0%+55.6%0.052% 8/6/2021HighTower Advisors LLC30,035$57K0.0%+87.3%0.061% 5/19/2021Virtu Financial LLC149,593$253K0.0%+549.5%0.303% 5/19/2021Squarepoint Ops LLC142,133$240K0.0%N/A0.288% 5/17/2021Goldman Sachs Group Inc.24,555$41K0.0%-78.8%0.052% 5/13/2021Renaissance Technologies LLC872,408$1.47M0.0%+23.3%1.844% 5/12/2021Geode Capital Management LLC259,243$438K0.0%+22.8%0.548% 5/12/2021CIBC Private Wealth Group LLC25,000$42K0.0%N/A0.053% 5/10/2021HighTower Advisors LLC16,035$27K0.0%-49.9%0.034% 5/4/2021Commonwealth Equity Services LLC16,625$28K0.0%N/A0.035% 2/10/2021HighTower Advisors LLC32,034$42K0.0%+33.3%0.077% 2/4/2021GSA Capital Partners LLP144,323$193K0.0%N/A0.347% (Data available from 1/1/2016 forward) DARE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DARE shares? During the previous two years, the following institutional investors and hedge funds held shares of Daré Bioscience shares: Armistice Capital LLC ($2.99M), Renaissance Technologies LLC ($262K), and Founders Financial Securities LLC ($95K), Virtu Financial LLC ($34K).Learn more on DARE's institutional investors. What percentage of Daré Bioscience stock is owned by institutional investors? 6.70% of Daré Bioscience stock is owned by institutional investors. Learn more on DARE's institutional investor holdings. Which institutional investors have been buying Daré Bioscience stock? The following institutional investors have purchased Daré Bioscience stock in the last 24 months: Armistice Capital LLC ($6.47M), Renaissance Technologies LLC ($15.80K), and Virtu Financial LLC ($15.42K). How much institutional buying is happening at Daré Bioscience? Institutional investors have bought a total of 6,501,223 shares in the last 24 months. This purchase volume represents approximately $36.10M in transactions. Which Daré Bioscience major shareholders have been selling company stock? The following institutional investors have sold Daré Bioscience stock in the last 24 months: Founders Financial Securities LLC ($233.82K), and Virtu Financial LLC ($44.99K). How much institutional selling is happening at Daré Bioscience? Institutional investors have sold a total of 278,812 shares in the last 24 months. This volume of shares sold represents approximately $2.89M in transactions. Related Companies Vistagen Therapeutics Major Shareholders Journey Medical Major Shareholders OptiNose Major Shareholders Rani Therapeutics Major Shareholders PDS Biotechnology Major Shareholders Seres Therapeutics Major Shareholders Onconetix Major Shareholders I-Mab Major Shareholders Purple Biotech Major Shareholders Checkpoint Therapeutics Major Shareholders This page (NASDAQ:DARE) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daré Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daré Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.